InsidersTradesSigma
Follow the 삼성에피스홀딩스 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 삼성에피스홀딩스 has recorded 12 reports. Market capitalisation: €8,659.3bn. The latest transaction was disclosed on 1 April 2026 (Sale). Among the most active insiders: 삼성에피스홀딩스. Every trade is accessible without an account.
Analysts rate 삼성에피스홀딩스 Buy (bullish), based on 2 analysts. Average price target: ₩600,000.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
12 of 12 declarations
Samsung Epise Holdings es una empresa farmacéutica y de atención médica que cotiza en el mercado XKRX. Se centra en el desarrollo y la comercialización de productos farmacéuticos innovadores.